Kenneth Hoberman - 13 Jun 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Kenneth Hoberman
Issuer symbol
NVCT
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 16:22:01 UTC
Previous filing
29 Sep 2023
Next filing
20 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +30,000 +41% $0.000000 103,140 13 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates.